NEW YORK, October 22, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Time Warner Inc. (NYSE: TWX), Walgreen Company (NYSE: WAG), Urban Outfitters, Inc. (NASDAQ: URBN), Wynn Resorts, Limited (NASDAQ: WYNN) and Bed Bath & Beyond Inc. (NASDAQ: BBBY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7371-100free.

-- Time Warner Inc. Research Reports On October 15, 2014, Richard Plepler, HBO's Chairman and CEO, while speaking at Time Warner Inc.'s (Time Warner) Investor Meeting held on October 15, 2014, reported that HBO will offer a stand-alone HBO streaming service in 2015. A portion of Plepler's presentation focused on HBO's, which is an indirect subsidiary of Time Warner, domestic business, during which he cited significant growth opportunities inside the pay-TV universe, before he talked about the current ten million broadband-only homes that is projected to grow. Plepler said, "That is a large and growing opportunity that should no longer be left untapped. It is time to remove all barriers to those who want HBO. So, in 2015, we will launch a stand-alone, over-the-top, HBO service in the United States. We will work with our current partners. And, we will explore models with new partners. All in, there are 80 million homes that do not have HBO and we will use all means at our disposal to go after them." The full research reports on Time Warner are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/TWX/report.pdf

-- Walgreen Company Research Reports On October 3, 2014, Walgreen Company (Walgreens) reported its September 2014 and 9M 2014 sales results. The Company reported September 2014 sales of c. $6.5 billion, up 9.4% YoY, while the Company's 9M 2014 sales improved 6.1% YoY to $57.4 billion. During the month, the Company's total comparable sales improved 7.9%, including a positive impact of 1.8% related to shifting of calendar; total front-end sales increased 2.2%; comparable Front End sales improved 1.7%; pharmacy sales increased by 14.2%; comparable Rx Sales improved 11.3%; and comparable Rx Scripts improved 6.6%. In September 2014, the Company opened nine stores, including four relocations, and closed four. The full research reports on Walgreens are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/WAG/report.pdf

-- Urban Outfitters, Inc. Research Reports On October 16, 2014, Urban Outfitters, Inc. (Urban Outfitters) released a business update stating that its Q3 2014 negative comparable retail segment net sales, as reported in its Form 10-Q filed in early September 2014, has continued quarter-to-date. Urban Outfitters further stated that due to the lower than expected sales, the Company believes its gross profit margin may deleverage for the Q3 2014 at a rate greater than it was during H1 2014. The Company informed that the occurrence of above stated event will have negative impact on the Company's Q3 2014 earnings. The full research reports on Urban Outfitters are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/URBN/report.pdf

-- Wynn Resorts, Limited Research Reports On October 14, 2014, Wynn Resorts, Limited (Wynn Resorts) reported that the Company's Chairman and CEO, Steve Wynn, was recognized in Harvard Business Review's 2014 list of "The Best-Performing CEOs in the World." The Company informed that Harvard Business Review's 2014 placed Mr. Wynn on 17th position out of 100 CEOs. Further, this prestigious recognition is based on quantitative data, while evaluating which CEOs delivered the most concrete results during their tenure. The full research reports on Wynn Resorts are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/WYNN/report.pdf

-- Bed Bath & Beyond Inc. Research Reports On October 17, 2014, shares in Bed Bath & Beyond Inc. (Bed Bath & Beyond) advanced 1.12% to close Friday's session at $63.10. Shares in Bed Bath & Beyond opened the session at $63.00 and oscillated in the range of $62.30 - $63.49. A total of 6.24 million shares changed hands during the session, which is above its 30-day average volume of 3.48 million shares. The stock has a 52-week high of $80.82 and a 52-week low of $54.96. Over the past three months, the stock has gained 2.35%, outperforming the Nasdaq Composite that lost 3.92% over the same period of time. The full research reports on Bed Bath & Beyond are available to download free of charge at:

http://www.analystsreview.com/Oct-22-2014/BBBY/report.pdf

-- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

=============== EDITOR'S NOTES: ===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Analysts Review